|
Volumn 907, Issue 1-2, 2001, Pages 100-108
|
Serotonergic lesion of median raphe nucleus alters nerve growth factor content and vulnerability of cholinergic septohippocampal neurons in rat
|
Author keywords
Alzheimer's disease; Choline acetyltransferase; Ethylcholine aziridinium (AF64A); Hippocampus; Neutrophin
|
Indexed keywords
5 HYDROXYINDOLEACETIC ACID;
5,7 DIHYDROXYTRYPTAMINE;
BRAIN PROTEIN;
ETHYLCHOLINE MUSTARD AZIRIDINIUM;
NERVE GROWTH FACTOR;
NEUROTOXIN;
SEROTONIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BRAIN LEVEL;
CHOLINERGIC ACTIVITY;
CHOLINERGIC NERVE CELL;
CONTROLLED STUDY;
DEAFFERENTATION;
DORSAL RAPHE NUCLEUS;
FRONTAL CORTEX;
HIPPOCAMPUS;
INNERVATION;
MALE;
MEDIAN RAPHE NUCLEUS;
NERVE CELL LESION;
NERVE CELL NECROSIS;
NERVE PROJECTION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN CONTENT;
PROTEIN EXPRESSION;
RAT;
SEROTONINERGIC NERVE CELL;
5,7-DIHYDROXYTRYPTAMINE;
ACETYLCHOLINE;
ANIMALS;
AZIRIDINES;
BIOLOGICAL MARKERS;
CHOLINE;
CHOLINE O-ACETYLTRANSFERASE;
CHOLINERGIC FIBERS;
DRUG RESISTANCE;
HIPPOCAMPUS;
MALE;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
RAPHE NUCLEI;
RATS;
RATS, SPRAGUE-DAWLEY;
SEPTUM PELLUCIDUM;
SEROTONIN;
SEROTONIN AGENTS;
|
EID: 0035854590
PISSN: 00068993
EISSN: None
Source Type: Journal
DOI: 10.1016/S0006-8993(01)02611-7 Document Type: Article |
Times cited : (26)
|
References (63)
|